S'abonner

Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology - 25/11/21

Doi : 10.1016/S1473-3099(21)00191-2 
George R Thompson, ProfMD a, b, , Thuy Le, MD c, d, Ariya Chindamporn, PhD e, Carol A Kauffman, ProfMD f, g, Ana Alastruey-Izquierdo, PhD h, Neil M Ampel, ProfMD i, j, David R Andes, ProfMD k, Darius Armstrong-James, Prof l, Olusola Ayanlowo, ProfMD m, John W Baddley, ProfMD n, Bridget M Barker, ProfPhD o, Leila Lopes Bezerra, ProfPhD p, Maria J Buitrago, ProfPhD h, Leili Chamani-Tabriz, ProfMD q, Jasper F W Chan, ProfMBBS r, s, Methee Chayakulkeeree, ProfMD t, Oliver A Cornely, ProfMD u, v, Cao Cunwei, ProfMD w, Jean-Pierre Gangneux, ProfPhD x, Nelesh P Govender, ProfMD y, z, Ferry Hagen, PhD aa, ab, ac, Mohammad T Hedayati, ProfMD ad, Tobias M Hohl, ProfMD ae, af, Grégory Jouvion, ProfMD ag, ah, Chris Kenyon, ProfPhD ai, Christopher C Kibbler, ProfPhD aj, Nikolai Klimko, ProfMD ak, David C M Kong, ProfMD al, am, Robert Krause, ProfMD an, Low Lee Lee, ProfMD ao, Graeme Meintjes, ProfPhD ap, aq, ar, Marisa H Miceli, MD g, Peter-Michael Rath, ProfMD as, Andrej Spec, MD at, Flavio Queiroz-Telles, ProfMD au, Ebrahim Variava, ProfMBBCh av, Paul E Verweij, ProfMD aw, Ilan S Schwartz, MD ax, Alessandro C Pasqualotto, ProfMD ay, az
a Department of Internal Medicine, Division of Infectious Disease, UC Davis Medical Center, Sacramento, CA, USA 
b Department of Medical Microbiology and Immunology, University of California, Davis, CA, USA 
c Division of Infectious Diseases and International Health, Duke University School of Medicine, Durham, NC, USA 
d Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam 
e Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand 
f VA Ann Arbor Healthcare System, Ann Arbor, MI, USA 
g Department of Internal Medicine, Division of Infectious Diseases, University of Michigan, Ann Arbor, MI, USA 
h Mycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III, Madrid, Spain 
i Division of Infectious Diseases, Mayo Clinic, Phoenix, AZ, USA 
j Department of Internal Medicine, Division of Infectious Diseases, University of Arizona College of Medicine, Tucson, AZ, USA 
k Department of Internal Medicine, Division of Infectious Diseases, and Department of Medical Microbiology and Immunology, University of Wisconsin, Madison, WI, USA 
l Department of Infectious Diseases, Imperial College London, London, UK 
m Department of Medicine, Faculty of Clinical Sciences, University of Lagos, Lagos, Nigeria 
n Department of Internal Medicine, Division of Infectious Disease, University of Maryland School of Medicine, Baltimore, MD, USA 
o Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, AZ, USA 
p Cellular Mycology and Proteomics Laboratory, Rio de Janeiro State University, Rio de Janeiro, Brazil 
q Infectious Diseases Unit, Department of Internal Medicine, Saudi German Hospital Dubai, Dubai, UAE 
r State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China 
s Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China 
t Division of Infectious Diseases and Tropical Medicine, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand 
u Department of Internal Medicine, Excellence Center for Medical Mycology, University Hospital of Cologne, Cologne, Germany 
v Department of Internal Medicine, Division of Infectious Diseases, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany 
w Department of Dermatology and Venereology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China 
x Department of Internal Medicine, Division of Infectious Diseases, Rennes University, CHU Rennes, Inserm, IRSET-UMR_S 1085, Rennes, France 
y National Institute for Communicable Diseases, Division of the National Health Laboratory Service, Johannesburg, South Africa 
z Department of Internal Medicine, Division of Infectious Diseases, University of the Witwatersrand, Johannesburg, South Africa 
aa Westerdijk Fungal Biodiversity Institute, Utrecht, Netherlands 
ab Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, Netherlands 
ac Laboratory of Medical Mycology, Jining No 1 People’s Hospital, Jining, China 
ad Department of Medical Mycology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran 
ae Infectious Disease Service, Department of Medicine; Memorial Sloan Kettering Cancer Center, New York, NY, USA 
af Immunology Program, Sloan Kettering Institute, New York, NY, USA 
ag Sorbonne Université, INSERM, Pathophysiology of Pediatric Genetic Diseases, Assistance Publique-Hôpitaux de Paris, Hôpital Armand-Trousseau, UF Génétique Moléculaire, Paris, France 
ah Institut Pasteur, Experimental Neuropathology Unit, Paris, France 
ai Institute of Tropical Medicine, Antwerp, Belgium 
aj Centre for Medical Microbiology, University College London, London, UK 
ak Department of Clinical Mycology, Allergy, and Immunology, I Mechnikov North-Western State Medical University, St Petersburg, Russia 
al Pharmacy Department, Ballarat Health Services, Ballarat, VIC, Australia 
am National Centre for Antimicrobial Stewardship, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia 
an Section of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Medical University of Graz, Graz, Austria 
ao Department of Internal Medicine, Hospital Sultanah Bayiyah, Alor Setar, Kedah, Malaysia 
ap Wellcome Centre for Infectious Diseases Research, University of Cape Town, Cape Town, South Africa 
aq Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa 
ar Department of Medicine, University of Cape Town, Cape Town, South Africa 
as Institute of Medical Microbiology, University Hospital Essen, Essen, Germany 
at Division of Infectious Disease, Washington University School of Medicine, St Louis, MO, USA 
au Department of Public Health, Hospital de Clínicas, Federal University of Paraná, Curitiba, Brazil 
av Department of Medicine, University of the Witwatersrand, Johannesburg, South Africa 
aw Department of Medical Microbiology, Excellence Center for Medical Mycology, Radboudumc-CWZ Center of Expertise for Mycology, Radboud University Medical Center, Nijmegen, Netherlands 
ax Division of Infectious Diseases, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada 
ay Department of Clinical Medicine, Federal University of Health Sciences of Porto Alegre Porto Alegre, Brazil 
az Molecular Biology Laboratory, Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Brazil 

* Correspondence to: Prof George R Thompson III, Department of Internal Medicine, Division of Infectious Diseases, UC Davis Medical Center, Sacramento, CA 95817, USA Department of Internal Medicine Division of Infectious Diseases UC Davis Medical Center Sacramento CA 95817 USA

Summary

The global burden of the endemic mycoses (blastomycosis, coccidioidomycosis, emergomycosis, histoplasmosis, paracoccidioidomycosis, sporotrichosis, and talaromycosis) continues to rise yearly and these infectious diseases remain a leading cause of patient morbidity and mortality worldwide. Management of the associated pathogens requires a thorough understanding of the epidemiology, risk factors, diagnostic methods and performance characteristics in different patient populations, and treatment options unique to each infection. Guidance on the management of these infections has the potential to improve prognosis. The recommendations outlined in this Review are part of the “One World, One Guideline” initiative of the European Confederation of Medical Mycology. Experts from 23 countries contributed to the development of these guidelines. The aim of this Review is to provide an up-to-date consensus and practical guidance in clinical decision making, by engaging physicians and scientists involved in various aspects of clinical management.

Le texte complet de cet article est disponible en PDF.

Plan


© 2021  Elsevier Ltd. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 21 - N° 12

P. e364-e374 - décembre 2021 Retour au numéro
Article précédent Article précédent
  • Effect on genital warts in Australian female and heterosexual male individuals after introduction of the national human papillomavirus gender-neutral vaccination programme: an analysis of national sentinel surveillance data from 2004–18
  • Eric P F Chow, Allison Carter, Tobias Vickers, Christopher K Fairley, Anna McNulty, Rebecca J Guy, David G Regan, Andrew E Grulich, Denton Callander, Laila Khawar, Dorothy A Machalek, Basil Donovan
| Article suivant Article suivant
  • Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM
  • Sharon C-A Chen, John Perfect, Arnaldo L Colombo, Oliver A Cornely, Andreas H Groll, Danila Seidel, Kerstin Albus, Joao N de Almedia, Guillermo Garcia-Effron, Nicole Gilroy, Cornelia Lass-Flörl, Luis Ostrosky-Zeichner, Livio Pagano, Tamas Papp, Riina Rautemaa-Richardson, Jon Salmanton-García, Andrej Spec, Joerg Steinmann, Sevtap Arikan-Akdagli, Dorothee E Arenz, Rosanne Sprute, Luisa Duran-Graeff, Tomas Freiberger, Corrado Girmenia, Michelle Harris, Souha S Kanj, Maryam Roudbary, Olivier Lortholary, Joseph Meletiadis, Esther Segal, Felipe Francisco Tuon, Nathan Wiederhold, Tihana Bicanic, Jagdish Chander, Yee-Chun Chen, Po-Ren Hsueh, Margaret Ip, Patricia Munoz, Isabel Spriet, Elvis Temfack, Luis Thompson, Anna Maria Tortorano, Aristea Velegraki, Nelesh P Govender

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.